
Currently out of the existing stock ratings of Dan Leonard, 236 are a BUY (60.98%), 130 are a HOLD (33.59%), 21 are a SELL (5.43%).
Analyst Dan Leonard, currently employed at RBC, has had 68.09% of price targets met with an average potential upside of 17.46%, reached in 281 days on average. Previously, Dan Leonard worked at WELLS FARGO, CREDIT SUISSE.
Dan Leonard has documented 841 price targets and ratings displayed on 48 stocks. The coverage is on Healthcare, Basic Materials, Industrials sectors.
Most recent stock forecast was given on QGEN, Qiagen NV.
Analyst best performing recommendations are on STVN (STEVANATO GROUP SPA).
The best stock recommendation documented was for CRL (CHARLES RIVER LABORATORIES) on 2/25/2026. The price target of $175 was fulfilled within 1 day with a profit of $7.44 (4.44%), with a performance score of 44.4.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 26-Feb-2026
$195
$21.04 (12.09%)
$150
1 months 9 days ago
(07-Oct-2026)
21/22 (95.45%)
$25.91 (15.32%)
140
Buy Since 25-Nov-2025
$185
$11.04 (6.35%)
$155
2 months 20 days ago
(27-Aug-2026)
30/31 (96.77%)
$27.31 (17.32%)
448
Buy Since 27-Feb-2026
$175
$1.04 (0.60%)
$150
2 months 20 days ago
(27-Aug-2026)
2/2 (100%)
$17.31 (10.98%)
103
Buy Since 02-Jun-2026
$180
$6.04 (3.47%)
$155
2 months 20 days ago
(27-Aug-2026)
5/5 (100%)
$22.31 (14.15%)
100
Buy Since 09-Oct-2025
$190
$16.04 (9.22%)
$180
2 months 20 days ago
(27-Aug-2026)
2/3 (66.67%)
$32.31 (20.49%)
343
Which stock is Dan Leonard most bullish on?
Which stock is Dan Leonard most reserved on?
What Year was the first public recommendation made by Dan Leonard?